throbber
[CANCER RESEARCH 51, 5817-5820, November 1, 1991]
`
`Common Regions of Deletion on Chromosomes 5q, 6q, and lOq in Renal
`Cell Carcinoma
`
`Ryoji Morita, Susumu Saito, Jiro Ishikawa, Osamu Ogawa, Osamu Yoshida, Kazuhiro Yamakawa,
`and Yusuke Nakamura1
`
`Department of Biochemistry, Cancer Institute, Kami-ikebukuro, Toshima-ku, Tokyo 170, Japan ¡R.M., S. S., K. Y., Y. N.J; Department of Genetics Research Laboratory,
`SRL, Inc., Komiya-machi, Hachioji City, Tokyo 192, Japan ¡R.M., S. S.J; Center for Biotechnology, Baylor College of Medicine, Woodlands, Texas 77381 ¡J.I.]; and
`Department of Urology, Faculty of Medicine, Kyoto University, Shogoin-kawahara-cho 54, Sakyo-ku, Kyoto 606, Japan [O. O., O. Y.]
`
`ABSTRACT
`
`5q, 6q,
`on chromosomes
`losses of heterozygosity
`frequent
`Relatively
`on the short arm of
`and lOq,
`in addition to loss of heterozygosity
`chromosome
`3, have been observed in renal cell carcinomas. As the first
`step toward isolation of tumor suppressor
`genes on these three chromo
`somal
`arms, we used six restriction
`fragment
`length polymorphism
`markers for 5q, nine for 6q, and eight for lOq to identify regions commonly-
`
`deleted in a panel of 64 renal cell carcinomas. Allelic losses were common
`at chromosome
`5q21,
`the region where the MCC (mutated in colorectal
`cancer) gene was recently identified; at chromosome
`6q27; and at chro
`mosome
`10q21-23.
`Furthermore,
`an association was observed between
`accumulation
`of allelic
`losses
`on these
`three chromosomal
`arms and
`progression of tumors. Loss of heterozygosity
`on chromosome S showed
`a correlation with the histopathological
`grade of a given tumor and the
`incidence of distant metastasis.
`
`INTRODUCTION
`to investigate the
`Numerous
`studies using RFLP2 markers
`molecular biology of carcinogenesis
`have suggested that an
`accumulation
`of genetic alterations
`at specific chromosomal
`loci contributes
`to tumor development
`and/or
`progression.
`Several genes,
`including
`oncogenes
`and tumor
`suppressor
`genes, appear
`to be involved in tumorigenesis
`of colon and
`breast cancers (1-3).
`In RCC, several lines of evidence point
`to
`the existence of a tumor suppressor gene(s) on the short arm of
`chromosome
`3: somatic
`chromosomal
`aberrations
`involving
`this chromosome
`(4, 5); t(3;8) balanced translocations
`in germ-
`line cells of some patients with hereditary renal cell carcinoma
`(6); and frequent LOH on chromosome 3p (7-10). Our earlier
`study suggested that,
`in addition to the gene on chromosome
`3p, tumor suppressor genes associated with RCC may exist on
`chromosomes
`5q, 6q,
`lOq,
`llq,
`and 17p (11). However,
`the
`frequency of LOH on these chromosomal
`arms was not as high
`as that on chromosome
`3p. To examine further whether
`these
`chromosomal
`arms contain tumor suppressor genes, and if they
`do, to map the loci precisely, we have analyzed these candidate
`loci in detail with a large number of RFLP markers. Addition
`ally, we have expanded the number of tumors
`investigated to
`64 and correlated the accumulation of events causing LOH on
`various chromosomal
`arms with clinical and histopathological
`parameters.
`
`MATERIALS AND METHODS
`
`from 64 patients with
`tissues
`and cancerous
`Materials. Normal
`primary sporadic RCC were obtained during radical nephrectomy at
`
`Received 6/19/91 ; accepted 8/13/91.
`The costs of publication of this article were defrayed in part by the payment
`of page charges. This article must
`therefore be hereby marked advertisement
`in
`accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
`of
`' To whom requests
`for
`reprints
`should be addressed,
`at Department
`Biochemistry, Cancer Institute, 1-37-1, Kami-ikebukuro. Toshima-ku, Tokyo 170,
`Japan.
`used are: RFLP,
`2The abbreviations
`phism; RCC, renal cell carcinoma: LOH,
`
`fragment
`restriction
`loss of heterozygosity.
`
`length polymor
`
`the School of Medicine, Kobe University,
`the Kobe National Hospital,
`or the Department
`of Urology, Kyoto University. The tissues were
`frozen immediately after nephrectomy and stored at -70°C until ex
`traction of DNA.
`DNA Extraction and Probes. The extraction of DNA from tissues
`was carried out according to methods described previously (3). All
`probes used in this study are listed in Table 1. The probes in the cCI6
`series were isolated from a human/mouse
`hybrid cell line which con
`tained only chromosome 6 as human-derived material
`(12) and were
`mapped by fluorescent
`in situ hybridization.'
`Southern Blotting and Hybridization. All DNA samples were trans
`ferred to nylon membrane (Pall Biodyne) with 0.1 N NaOH/0.1 M
`NaCl. Neutralization,
`fixation, and hybridization were done according
`to methods described previously (3).
`
`RESULTS
`
`the enzyme detecting RFLP, and
`localization,
`Chromosomal
`frequency of LOH for each probe are summarized in Table 1.
`Fig. 1 presents examples of deletion maps and Southern blots
`which show loss or retention of heterozygosity
`in tumors. A
`significant
`reduction of signal
`intensity was observed in one of
`two polymorphic
`alÃ(cid:173)elesin blots probed with CI6-39, CI6-49,
`and OS-2. On the other hand, polymorphic alÃ(cid:173)elesin blots with
`CI6-4, THH54,
`and MCT122.2 were retained in tumors. The
`results of LOH studies on four chromosomal
`arms (3p, 5q, 6q,
`and lOq) and the histopathological
`features of each tumor are
`summarized in Table 2. LOH was observed on chromosome
`3
`in 52 of 58 informative cases (90%). LOH also occurred fre
`quently on chromosomes
`5q (13 of 39, 33%), 6q (17 of 44,
`39%), and lOq (25 of 61, 41%). However, LOH on chromo
`somes llq (3 of 26, 12%), 17p (13 of 63, 21%), and 19p (8 of
`55, 15%) was not observed as frequently as in our previous
`study.
`deletion maps of
`In view of these results, we constructed
`chromosomes
`5q, 6q, and lOq. On chromosome
`5q, Tumor 5
`showed LOH with RFLP marker pL5.71-3, but retained both
`alÃ(cid:173)elesat proximal
`loci defined by E5.55 and LS5.3. Tumors
`35 and 94 lost one alÃ(cid:173)eleat
`the L5.71 locus but
`retained
`heterozygosity at the distal YN5.48 locus. From these results,
`a common region of deletion was identified at chromosome
`5q21, where the gene responsible
`for adenomatous
`polyposis
`coli
`is located (Fig. 2a). On chromosome
`6q (Fig. 2b), a
`commonly deleted region was identified at q27:
`the tumor of
`Patient 22 lost an alÃ(cid:173)elein the region distal
`to cCI6-52; Tumor
`33 showed LOH in the region distal
`to cCI6-91; and Tumor
`104 lost a part distal
`to cCI6-4.
`In Fig. 2c, a deletion map of
`chromosome
`lOq shows that Tumor 6 lost an alÃ(cid:173)eleat cTBQ16
`but retained both alÃ(cid:173)elesat pEFD75, Tumor 90 showed LOH
`at THH54
`but
`retained both OS-2 alÃ(cid:173)eles,and Tumor
`104
`showed LOH at OS-2 but retained heterozygosity at THH54
`and MCT122.2. Therefore, a common region of deletion was
`
`3S. Saito et al., unpublished data.
`
`5817
`
`West-Ward Exhibit 1099
`Morita 1991
`Page 001
`
`

`

`COMMON REGIONS OF DELETION ON CHROMOSOMES
`
`5q, 6q, AND I0<j IN RCC
`
`10q
`
`104 on
`Fig. 1. Deletion maps of Tumor
`chromosomes 6q and lOq and typical Southern
`blots demonstrating
`loss or retention of het-
`erozygosity in DNAs from normal kidney (A1)
`and from renal cell carcinoma (T). Al, A2. and
`C indicate alÃ(cid:173)eleI (larger fragment), alÃ(cid:173)ele2
`(smaller fragment), and invariant band, respec
`tively. •¿(cid:3).LOH; D. retained; B. uninformative.
`
`N T
`
`•¿(cid:3)«-A1
`•¿(cid:3)•¿(cid:3)«-A2
`
`«-A1
`
`«-A2
`
`6q
`
`104
`
`CI6-52
`
`CI6-4
`
`CI6-91
`
`CI6-13
`
`CI6-39
`
`CI6-49
`
`JCZ30
`
`
`
`Table 1 Probes tested for loss ofhelerozygosilyProbeChromosome
`
`5
`E5.S5L5.71-3YN5.48-4LS5.3-4
`
`MC5.61KK5.19Total
`
`(chromosome5q)Chromosome
`
`6
`HHH157CI6-7CI6-47
`
`CI6-37
`C16-52CI6-3CI6-4
`
`D6S154
`q21
`D6S164D6S135D6S136
`q23q24q25
`
`(22)
`3/15(20)
`Taql
`1/11(9)5/9
`Msp\Msp\Mspl
`(56)2/16(13)
`
`the q21-q23 band of
`
`between THH54 and OS-2 at
`chromosome
`10.
`between
`
`
`to find correlationsWe attemptedchromosomalalterations
`3,the
`and histopathological
`features. As shown in Fig.
`
`accumulated number of LOHs on chromosomes 3p, 5q,6q,and
`lOq in each tumor showed a correlation with its histopath
`
`ological grade. In the clear cell type of RCC, LOH wasdetectedat
`(17)"8/26(31)5/28(18)3/16(19)
`
`two or more of these chromosomalofmoderately
`arms tested in 82%
`detectedat
`differentiated tumors, although LOH was
`
`only one chromosomalthewell-differentiated
`arm or not at all in nearly half of
`D5S84D6S29D6S138D6S160
`q21q32P21p21.3p21.2
`2/5(40)2/10(20)13/39(33)3/22(14)6/34(18)5/23
`Taq\Rsal//«millPstlBgl\\
`types. The results suggest
`that an accumu
`lation of events causing LOH (probably reflecting loss of func
`tion of tumor suppressor genes) is associated with tumor pro
`gression.
`In particular, LOH on 5q showed a significant corre
`lation with tumor grade (Fisher's
`test, P —¿(cid:3)0.015) and a weak
`association with distant metastasis (P = 0.062) (Table 3). How
`
`ever, stage and tumor size were not correlated with thenumberof
`
`chromosomalLOHs.DISCI
`arms showing
`
`CI6-91CI6-13CI6-39CI6-49JCZ30Total
`D6S186D6S142D6S156D6S161D6S37D10S28
`q26q27q27q27027M**
`7/34(21)8/30
`Msp\Msp]Taq\Taq\Taa\*
`(27)7/27
`(26)6/27
`ISSIONL/lkJ\_-
`(22)9/25
`(36)17/44(39)3/31
`geneson
`lines of evidence have suggested that one or more
`the short arm of chromosome
`3 are associated with devel
`(10)
`
`opment and/or progressionofheterozygosity
`of renal cell carcinomas:
`loss
`
`1/11(9)2/13(15)3/10(30)
`Msp\MsplMspl
`(7-10); cytogenetic aberrations
`(4, 5) and hered
`translocations
`(6); or von Hippel-Lindau
`disease
`itary t(3;8)
`3/15(20)
`
`( 13, 14). In a previous study, we detected two commonlydeletedregions
`5/17(29)9/32
`at chromosomes 3pl4 and 3p21.3 in RCCs (10). How
`(28)8/25
`(32)
`
`ever, studies on colorectal carcinoma(15,16),
`(1, 2), lung cancer
`q22-q25q26q26ql2-ql3.2ql2-ql3.2«13p
`D10S27D10S36D10S25PYGMD11S146INT2D17S5
`3/26(12)5/27(19)10/30(33)25/61
`MsplTaq\TaqlMsplTaqlTaqlTaql
`and breast cancerthatalterations
`
`(Ref. 3; Footnote 4) have shown
`in oncogenes and tumor suppressor genes accumu
`(41)2/15(13)1/15(7)3/9
`
`late to transform a normalthepresent
`cell
`to a malignant
`cell.
`In
`
`study, we have investigatedfivechromosomal
`additional
`loci on
`wereimplicated
`arms
`(5q, 6q,
`lOq, 17p, and 19q) that
`
`by LOH in our previous studies (1 1) to examinethesignificance
`of the allelic losses at
`these loci. Although chro
`13.3
`
`mosomes 17p and 19q did not show the frequency ofLOHreported
`pl3.1-pll.2P13p
`5/28(18)4/20
`D17S31P53D19S21D19S20Locationq21q21q21q21
`MsplBamHlPstlTaqlMsplLOH/informativecases1/6
`to41%
`previously,
`the other
`three regions
`revealed 33%
`(20)13/63(21)3/30(10)8/40
`
`LOH, and commonly deleted regions were identifiedat5q21,6q27,
`and10q21-q23.Kovacs
`
`and Kung (17) and Presti et al. (18) reported cytoge
`(20)7/48(15)8/55(15)assigned
`netic abnormalities on chromosome 5 due to unbalanced trans-
`13.3EnzymeTaqlMsplMsplMsp\
`(chromosome 19p)SymbolD5S133D5SI41D5S81D5S140
`1Numbers in parentheses, percentage.
`
`/pter-pl3
`
`
`
`"f•¿(cid:3)Mspl
`
`
`
`UOOlV/1^1Many
`
`(chromosome6q)Chromosome
`
`10TBQ7
`
`MHZ15TBQ16TB10.163
`
`
`pter-p 13qllq21
`D10S17D10S30D10S22
`
`CMMI7.4
`THH54HHH105OS-2
`
`Pvull
`D10S23
`q21q21q22-q25q22-q25
`D10S14D10SI3D10S20
`MsplB
`filliHindlll
`
`TBQ4MCT
`122.2EFD75Total
`
`(chromosome
`
`Chromosome 11MCMPIHBIS9SS6
`
`lOq)
`
`Total (chromosome 1Iq)Chromosome
`
`17YNZ22
`
`MCT35.1BHP53Total
`
`(chromosome17p)Chromosome
`
`19
`MCOB5JCZ3.1YNZ21Total
`
`(33)
`3/26(12)8/48(17)
`
`13.3pl3.3p
`
`4T. Sato et al., unpublished data.
`
`5818
`
`West-Ward Exhibit 1099
`Morita 1991
`Page 002
`
`

`

`COMMON REGIONS OF DELETION ON CHROMOSOMES
`
`5q. 6q. AND lOq IN RCC
`
`Table 2 (jenolype and histopathological features of tumors
`armPatient
`Genotype of each
`
`3p
`
`type*O
`
`Grade"
`
`5q3
`rII
`014
`—¿(cid:3)15
`019
`02122
`
`026
`—¿(cid:3)29
`032
`034
`037
`•¿(cid:3)51
`053
`054
`•¿(cid:3)5786
`
`•¿(cid:3)8788
`
`091
`092
`094
`•¿(cid:3)95
`097100
`
`0104
`01055
`
`•¿(cid:3)6
`07
`016
`—¿(cid:3)17
`•¿(cid:3)18
`•¿(cid:3)20
`—¿(cid:3)23
`•¿(cid:3)2425
`
`•¿(cid:3)33
`035
`•¿(cid:3)38
`039
`•¿(cid:3)43
`•¿(cid:3)834155
`
`—¿(cid:3)89
`O96
`—¿(cid:3)101
`•¿(cid:3)36
`«040
`0082
`—¿(cid:3)84
`—¿(cid:3)85
`02
`08l
`—¿(cid:3)103
`—¿(cid:3)102
`—¿(cid:3)90
`099
`-98
`—¿(cid:3)52
`—¿(cid:3)5658
`
`—¿(cid:3)59
`
`C•
`C0
`CO
`CO
`C•
`C0
`CO
`C0
`C•
`C—
`C0
`C•
`CO
`C•
`C•
`C•
`CC•
`
`C0
`C0
`C0
`C0
`C0
`C•
`C•
`C0
`CO
`C•
`C0
`C•
`C•
`C0
`CO
`CO
`C•
`C•
`C0
`C0
`C0
`C•
`
`2
`2
`2
`2
`2
`2
`2
`2
`2
`2
`2
`2
`2
`2C2
`
`2
`3
`X
`1
`1
`1
`2
`2
`2
`2
`2
`3
`1
`1
`2
`1
`2
`3
`
`0
`
`•¿(cid:3)
`—¿(cid:3)
`•¿(cid:3)
`•¿(cid:3)
`0
`•¿(cid:3)
`•¿(cid:3)
`
`-
`•¿(cid:3)
`•¿(cid:3)
`
`C•
`C•
`CO
`C0
`GO
`G•
`G•
`GO
`GO
`G•
`G0
`GO
`S0
`C/G0
`C/G0
`C/G•
`C/G•
`C/G0
`G/S•
`XXO
`XO
`X
`•¿(cid:3)
`X
`X•
`MI2
`XX
`»06q&0__O—0•0———00•0•0—o0••0—o•00——0•——_—••——•o——•0o•—••••0—00—•0o00oCelilOq
`
`N=27
`
`N=17
`
`90
`of LOH
`39
`41
`" Grade of each tumor was determined according to the criteria of the Japanese
`Pathological Society (20).
`* C, clear cell type; G. granular cell type; S, spindle cell type; C/G, mixed type
`of clear and granular: G/S, mixed type of granular and spindle: X. not determined.
`' LOH was observed for at least one locus on this arm.
`d Uninformative at every locus on this arm.
`' Retention of hctero/ygosity at every locus on this arm.
`
`M<2
`
`3p and 5q with the breakpoints
`location between chromosomes
`at Bands 3p 13 and 5q22, resulting in an extra copy of the 5q22-
`qter region. It is likely that some of our cases may have partial
`trisomy of 5q. However,
`it was very hard to judge such partial
`trisomy due to difficulties of distinguishing gain of alÃ(cid:173)elefrom
`
`Grade
`Grade
`2or3
`1
`between tumor grade and the number of accumulated
`Fig. 3. Correlation
`mutations detected on four specific chromosomal
`arms (3p. 5q. 6q. and lOq) in
`clear cell carcinomas. M. number of mutations on these arms. Grade I, well
`differentiated: Grades 2 or 3. moderately differentiated.
`
`5819
`
`loss of alÃ(cid:173)eleon Southern blots. We have indicated that a gene
`on chromosome
`5q may be associated with progression
`of
`RCCs. As the commonly deleted region at chromosome
`5q
`includes
`the L5.71 locus, which is a genomic clone of the
`recently ascertained MCC (mutated in colorectal cancer) gene
`(19), the MCC gene might be a candidate for a role in RCC.
`
`05
`
`E
`D
`
`104
`
`D
`E
`
`35
`
`94
`
`D
`D
`El
`D
`
`82
`
`BBD H
`
`D
`E
`D
`B
`
`ED
`
`5D
`
`22
`
`D0B
`
`I0q
`
`TBQI6
`TB10I63
`CMM174
`
`52
`
`90
`
`104
`
`16
`
`D
`
`E3
`
`D BD
`
`DB0
`
`DD
`
`DD
`
`THH54
`HHHI05
`OS-2
`
`21
`
`24
`
`25 Ik
`
`TBQ4
`MCI1222
`EFD75
`
`D
`Fig. 2. Deletion maps of 5q (a), 6q (ft), and lOq (r) in sporadic renal cell
`carcinoma. Common regions of deletion are indicated by a vertical bar on the
`
`right. •¿(cid:3)l.OH: D. retained: D uninformative.
`
`West-Ward Exhibit 1099
`Morita 1991
`Page 003
`
`

`

`COMMON REGIONS OF DELETION ON CHROMOSOMES
`
`5q. 6q. AND lOq IN RCC
`
`Table 3 Correlation between mutation on 5q and tumor grade or distant
`metastasis
`Histopathological
`
`metastasis*-167+4
`
`grade"Retained
`
`LOH11542
`°P= 0.015 (Fisher's test).
`" P= 0.062 (Fisher's test).
`
`or34
`
`8Distant
`
`(1, 2)
`carcinoma
`as in the case of colorectal
`Furthermore,
`and breast cancer (Ref. 3; Footnote 4), accumulation of genetic
`alterations was correlated with the grade of primary renal
`carcinomas. Our results suggested that alterations
`on 6q and
`lOq also are important
`to progression of RCC. Tumors
`from
`Patients 17, 25, 39, 40, and 101 retained heterozygosity at loci
`on chromosome
`3p, but they did show LOH on other chromo
`somal arms. These tumors may contain a very small interstitial
`deletion on chromosome
`3p which was not detectable by our
`panel of probes;
`it is also possible that an alternative pathway
`exists for development of RCC, without association of genes
`on 3p.
`
`REFERENCES
`
`tumorigenesis.
`
`1. Vogelstein, B.. Fearon, E. R., Kern. S. E.. Hamilton, S. R., Preisinger, A.
`C., Nakamura, Y., and White, R. Allelotype of colorectal carcinomas. Science
`(Washington DC), 244: 207-211, 1989.
`2. Fearon, E. R., Vogelstein, B. A genetic model for colorectal
`Cell, 61: 759-767, 1990.
`3. Sato, T., Tanigami, A., Yamakawa, K., Akiyama, F.. Kasumi, F., Sakamoto,
`G., and Nakamura, Y. Allelotype of breast cancer: cumulative alÃ(cid:173)elelosses
`promote tumor progression in primary breast cancer. Cancer Res., 50: 7184-
`7189, 1990.
`4. Yoshida, M. A., Ohyashiki, K.. Ochi. H., Gibas, Z., Pontes, J. E., Prout, G.
`R., Jr., and Sandberg, A. A. Cytogenetic studies of tumor
`tissue from a
`patient with nonfamilial
`renal cell carcinoma. Cancer Res., 46: 2139-2147,
`1986.
`5. Kovacs, G., Szucs, S., DeRiese. W., and Baumgartel, H. Specific chromosome
`aberration in human renal cell carcinoma. Cancer Res.. 40:171-178,
`1987.
`6. Cohen, A. J., Li, F. P., Berg, S., Marchetto, D. T., Tsai, S., Jacobs, S. C,
`and Brown, R. S. Hereditär)' renal cell carcinoma associated with a chro
`mosomal
`translocation. N. Engl. J. Med., 301: 592-595. 1979.
`
`7. Zbar, B., Brauch. H., Talmadge, C., and Lineham, M. Loss of alÃ(cid:173)elesof loci
`on the short arm of chromosome 3 in renal cell carcinoma. Nature (Lond.),
`327:721-724,
`1987.
`8. Kovacs, G.. Erlandsson, R.. Boldog, F., Ingvarsson. S., Muller-Brechlin, R.,
`Klein, G.. and Sumegi, J. Consistent chromosome 3p deletion and loss of
`heterozygosity in renal cell carcinoma. Proc. Nati. Acad. Sci. USA, 85:1571-
`1575, 1988.
`9. Bergerheim, U., Nordenskjold, M., and Collins, V. P. Deletion mapping in
`renal cell carcinoma. Cancer Res., 49: 1390-1396, 1989.
`J., and
`Ishikawa,
`10. Yamakawa, K., Morita. R., Takahashi, E., Hori, T.,
`Nakamura, Y. A detailed deletion mapping of the short arm of chromosome
`3 in sporadic renal cell carcinoma. Cancer Res., 51: 4707-4711,
`1991.
`11. Morita, R., Ishikawa, J., Tsutsumi, M., Hikiji, K., Tsukada, Y., Kamidono,
`S.. Maeda, S., and Nakamura. Y. Allelotype of renal cell carcinoma. Cancer
`Res., 51: 820-823. 1991.
`12. Koi, M.. Shimizu, M.. Morita, H., Yamada, H., and Oshimura, M. Construc
`tion of mouse A9 clones containing a single human chromosome tagged with
`neomycin-resistance gene via microcell fusion. Jpn. J. Cancer Res., 80: 413-
`418, 1989.
`13. King, C. R.. Schimke, R. N., Arthur, T., Davoren, B., and Collins, D.
`Proximal 3p deletion in renal cell carcinoma cells from a patient with von
`Hippel-Lindau disease. Cancer Genet. Cytogenet., 27: 345-348, 1987.
`14. Seizinger, B. R.. Rouleau, G. A., Ozelius, L. J., Laue, A. H., Farmer, G. E.,
`Lamiell, J. M.. Haines, J., Yuen, J. W. M., Collins, D., Majoor-Krakauer,
`D., Bonner. T.. Mathe».C., Runenstein. A., Halperin, J., McConkie-Rosell,
`A., Green, J. S., Trofatter,
`J. A., Ponder, B. A., Eierman, L., Bowmer, M.
`S., Schimke, R.. Oostra, B., Aronin. N.. Smith, D. L, Drabkin, H.. Waziri,
`M. H., Hobbs, W. J., Martuza, R. L., Conneally, P. M., Hsia, Y. E., and
`Gusella. J. F. Von Hippel-Lindau disease maps to the region of chromosome
`3 associated with renal cell carcinomas. Nature (Lond.), 332: 268-269, 1988.
`15. Naylor, S. L., Johnson, B. E.. Minna, J. D., and Sakaguchi, A. Y. Loss of
`heterozygosity of chromosome 3p markers in small-cell
`lung cancer. Nature
`(Lond.), 329: 451-454, 1987.
`16. Kok, K., Osigna, J., Carri«, B., Davis, M. B., van der Hout, A. H., van der
`Veen, A. Y., Landsvater, R. M., de liji, L. F. M. H., Berendsen, H. H.,
`Postmus, P. E., Poppema, S., and Buys, C. H. M. Deletion of a DNA
`sequence at chromosomal
`region 3p21 in all major
`types of lung cancer.
`Nature (Lond.), 330: 578-581, 1987.
`17. Kovacs. G., and Kung, H. Nonhomologous chromatid exchange in hereditary
`and sporadic renal cell carcinomas. Proc. Nati. Acad. Sci. USA, 88: 194-
`198, 1991.
`18. Presti, J. C., Rao. P. H., Chen, Q.. Reuter, V. E., Li, F. P., Fair, W. R., and
`Jhanwar, S. C. Histopathological,
`cytogenetic, and molecular characteriza
`tion of renal cortical
`tumors. Cancer Res., 51: 1544-1552, 1991.
`19. Kinzler, K. W., Nilbert, M. C., Vogelstein, B., Bryan, T. M., Levy, D. B.,
`Smith, K. J.. Preisinger, A. C.. Hamilton, S. R., Hedge, P., Markhan, A.,
`Carlson, M., Joslyn, G., Groden,
`J., White, R., Miki, Y., Miyoshi, Y.,
`Nishisho,
`I., and Nakamura, Y. Identification of a gene located at chromo
`some 5q21 that
`is mutated in colorectal cancers. Science (Washington DC),
`251: 1366-1370. 1991.
`the Japanese Pathological Society, and
`20. Japanese Urologica! Association,
`Japan Radiological Society. General Rules for Clinical and Pathological
`Studies on Renal Cell Carcinoma, Ed. 1, pp. 68-73. Tokyo: Kanehara, 1983.
`
`5820
`
`West-Ward Exhibit 1099
`Morita 1991
`Page 004
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket